Literature DB >> 2842910

Biochemical changes before and during oral calcium tolerance test in calcium stone formers.

T Kitamura1, Y Hirano, D Ueda, Y Aso.   

Abstract

116 normocalcemic and 8 primary hyperparathyroid (PHPT) patients with calcium (Ca) nephrolithiasis and 10 normal controls underwent 1 g of oral Ca tolerance test following 4 days of Ca restricted diet (400 mg/day). On the basis of urinary Ca/creatinine (Cr) ratio obtained by the test, the 116 patients with normocalcemic nephrolithiasis were divided into 3 groups (normocalciuric nephrolithiasis; NN, absorptive hypercalciuria; AH, renal hypercalciuria; RH) according to our criteria which were slightly modified from Pak et al. Changes in urinary Ca/Cr ratio, and those in serum Ca and phosphorus (P), tubular maximum reabsorption of phosphate/glomerular filtration rate (TmPO4/GFR), nephrogenous adenosine 3',5'-monophosphate (NcAMP) and plasma immunoreactive parathyroid hormone (iPTH) were determined. As a result, the 116 patients were divided into 82NN, 13AH and 21RH. In general, a rise in serum Ca and fall in NcAMP were seen first, followed by rises in urinary Ca/Cr ratio, serum P and TmPO4/GFR although the changes were small. The group PHPT showed abnormality in the changes of TmPO4/GFR, NcAMP and plasma iPTH. The former one decreased constantly during the test and the latter two did not fall to within the normal range, suggesting parathyroid autonomy or abnormal suppressibility. Regarding the normal controls, all the changes were smallest among the 5 groups and clear parathyroid suppression was not observed while it was seen in the groups NN, AH and RH. In conclusion, oral Ca tolerance test is useful not only to separate NN, AH and RH, but also for the diagnosis of PHPT by demonstrating parathyroid autonomy or abnormal suppressibility assessed by NcAMP and/or TmPO4/GFR.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2842910     DOI: 10.1007/BF00256009

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  13 in total

1.  On certain physiologic responses to intravenous injection of calcium salts into normal hyperparathyroid and hypoparathyroid persons.

Authors:  J E HOWARD; T R HOPKINS; T B CONNOR
Journal:  J Clin Endocrinol Metab       Date:  1953-01       Impact factor: 5.958

2.  Effects of the intravenous administration of calcium on nephrogenous cyclic AMP: use as a parathyroid suppression test.

Authors:  A E Broadus; L J Deftos; F C Bartter
Journal:  J Clin Endocrinol Metab       Date:  1978-03       Impact factor: 5.958

3.  A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias.

Authors:  C Y Pak; R Kaplan; H Bone; J Townsend; O Waters
Journal:  N Engl J Med       Date:  1975-03-06       Impact factor: 91.245

4.  Possibility of elevated parathyroid function in patients with calcium-containing nephrolithiasis as compared with normal controls.

Authors:  T Kitamura; Y Hirano; D Ueda; T Niijima
Journal:  Eur Urol       Date:  1987       Impact factor: 20.096

5.  How to differentiate hyperparathyroid patients among intermittent hypercalcemic urinary stone formers: a combined use of immunoreactive parathyroid hormone and nephrogenous adenosine 3',5'-monophosphate.

Authors:  T Kitamura; M Tanaka; K Abe; T Niijima
Journal:  J Urol       Date:  1980-03       Impact factor: 7.450

6.  Pathophysiological studies in idiopathic hypercalciuria: use of an oral calcium tolerance test to characterize distinctive hypercalciuric subgroups.

Authors:  A E Broadus; M Dominguez; F C Bartter
Journal:  J Clin Endocrinol Metab       Date:  1978-10       Impact factor: 5.958

7.  The pathogenesis of idiopathic hypercalciuria: evidence for parathyroid hyperfunction.

Authors:  R A Evans; E Hills; S Y Wong; L E Wyndham; Y Eade; C R Dunstan
Journal:  Q J Med       Date:  1984

8.  Nephrogenous cyclic adenosine monophosphate as a parathyroid function test.

Authors:  A E Broadus; J E Mahaffey; F C Bartter; R M Neer
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

9.  Responses to hydrochlorothiazide and acetazolamide in patients with calcium stones. Evidence suggesting a defect in renal tubular function.

Authors:  R A Sutton; V R Walker
Journal:  N Engl J Med       Date:  1980-03-27       Impact factor: 91.245

10.  Assessment of adenosine 3',5'-monophosphate excretion and an oral calcium tolerance test in the diagnosis of mild primary hyperparathyroidism.

Authors:  P Madvig; G Young; R Marcus
Journal:  J Clin Endocrinol Metab       Date:  1984-03       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.